The Quantellect read.As of Nov 19, 2026, 4 active firms cover Lucid Diagnostics Inc: 4 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. The target range is very wide, $2.00 to $9.50 (about 4.8x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $4.25 sits 957% above the current $0.40. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.04 next quarter toward $-0.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Buy
Strong Buy00%
Buy4100%
Neutral00%
Sell00%
Strong Sell00%
Based on 4 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$4.25
+957.2% upside
Average target across 4 active firms as of Nov 19, 2026 vs $0.40 current
Highest Target$9.50
Average Target$4.25
Lowest Target$2.00
Detailed analyst forecasts for LUCD
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 19, 2026, 4 of 4 active firms rate LUCD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
LUCD EPS & revenue forecast
EPS · NEXT QUARTER
$-0.04
Range $-0.04 – $-0.04 · 2 analysts · -43% YoY
Next period, 2 analysts expect Lucid Diagnostics Inc to earn $-0.04 a share (range $-0.04 – $-0.04), versus $-0.07 a year earlier. Full-year consensus is $-0.24, growing to $-0.17 the year after.
REVENUE · NEXT QUARTER
$2.4M
Range $1.8M – $3.0M · 2 analysts · +90% YoY
Revenue is expected to reach $2.4M (range $1.8M – $3.0M), +90.4% year-over-year. Full-year consensus is $5.6M, rising to $16.7M next year.
Top analysts covering Lucid Diagnostics Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LUCD.
#1
Mark Massaro
BTIG · Rank #220
Buy
$2.50+521.9% to target
Overall win rate
44%
+ Follow
#2
Ross Osborn
Cantor Fitzgerald · Rank #238
Buy
$3.00+646.3% to target
Overall win rate
34%
+ Follow
#3
Mike Matson
Needham · Rank #285
Buy
$3.00+646.3% to target
Overall win rate
36%
+ Follow
#4
Anthony Vendetti
Maxim Group · Rank #456
Buy
$2.00+397.5% to target
Overall win rate
28%
+ Follow
#5
Edward Woo
Ascendiant Capital · Rank #570
Buy
$9.50+2263.2% to target
Overall win rate
24%
+ Follow
LUCD stock forecast FAQ
What is LUCD's average 12-month price target?+
The 4 active firms with a live target average $4.25 for Lucid Diagnostics Inc over the next 12 months, ranging from a $9.50 high to a $2.00 low, as of Nov 19, 2026.
Is LUCD stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 4 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for LUCD?+
The Street-high target is $9.50 (Ascendiant Capital), and the Street-low is $2.00 (Maxim Group). The average of all 4 active-firm targets is $4.25.
How many active Wall Street firms cover LUCD?+
4 active firms have a recognized rating on Lucid Diagnostics Inc as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering LUCD?+
Among analysts who currently cover LUCD, Mark Massaro of BTIG has the strongest overall Quantellect track record (Rank #220). Their current call is Buy with a $2.50 target.
What is Lucid Diagnostics Inc's projected EPS for next quarter?+
The consensus estimate is $-0.04 per share (range $-0.04 – $-0.04) across 2 analysts. Full-year EPS is projected at $-0.24, rising to $-0.17 the following year.
How much revenue is Lucid Diagnostics Inc expected to report next quarter?+
Consensus revenue is $2.4M (range $1.8M – $3.0M). Full-year revenue is projected at $5.6M, growing to $16.7M next year.
Have analysts been upgrading or downgrading LUCD lately?+
As of Nov 19, 2026, 4 of 4 active firms rate LUCD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LUCD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.